Publications

Found 5 results
Filters: Author is Y. An  [Clear All Filters]
2016
L. Wei, An, Y., Wang, J., Wei, L., An, Y., and Wang, J., “Association between functional polymorphisms in the nitric oxide synthase 3 gene and pediatric acute respiratory distress syndrome”, vol. 15, p. -, 2016.
L. Wei, An, Y., Wang, J., Wei, L., An, Y., and Wang, J., “Association between functional polymorphisms in the nitric oxide synthase 3 gene and pediatric acute respiratory distress syndrome”, vol. 15, p. -, 2016.
2015
X. H. Liu, Xie, C. G., An, Y., Zhang, X. X., and Wu, W. B., “Meta-analysis of the association between the rs7903146 polymorphism at the TCF7L2 locus and type 2 diabetes mellitus susceptibility”, vol. 14, pp. 16856-16862, 2015.
Y. An, Li, H., Wang, K. J., Liu, X. H., Qiu, M. X., Liao, Y., Huang, J. L., and Wang, X. S., “Meta-analysis of the relationship between slow acetylation of N-acetyl transferase 2 and the risk of bladder cancer”, vol. 14, pp. 16896-16904, 2015.
2012
Z. W. Liu, Liu, J. L., An, Y., Zhang, L., and Wang, Y. M., “Association between Ser311Cys polymorphism in the dopamine D2 receptor gene and schizophrenia risk: a meta-analysis in Asian populations”, vol. 11, pp. 261-270, 2012.
Andreasen NC, Arndt S, Alliger R, Miller D, et al. (1995). Symptoms of schizophrenia. Methods, meanings, and mechanisms. Arch. Gen. Psychiatry 52: 341-351. http://dx.doi.org/10.1001/archpsyc.1995.03950170015003 PMid:7726714 Arinami T, Itokawa M, Enguchi H, Tagaya H, et al. (1994). Association of dopamine D2 receptor molecular variant with schizophrenia. Lancet 343: 703-704. http://dx.doi.org/10.1016/S0140-6736(94)91581-4 Arinami T, Itokawa M, Aoki J, Shibuya H, et al. (1996). Further association study on dopamine D2 receptor variant S311C in schizophrenia and affective disorders. Am. J. Med. Genet. 67: 133-138. http://dx.doi.org/10.1002/(SICI)1096-8628(19960409)67:2<133::AID-AJMG2>3.0.CO;2-T Chen CH, Chien SH and Hwu HG (1996). No association of dopamine D2 receptor molecular variant Cys311 and schizophrenia in Chinese patients. Am. J. Med. Genet. 67: 418-420. http://dx.doi.org/10.1002/(SICI)1096-8628(19960726)67:4<418::AID-AJMG19>3.0.CO;2-M Fan H, Zhang F, Xu Y, Huang X, et al. (2010). An association study of DRD2 gene polymorphisms with schizophrenia in a Chinese Han population. Neurosci. Lett. 477: 53-56. http://dx.doi.org/10.1016/j.neulet.2009.11.017 PMid:19913597 Fatemi SH and Folsom TD (2009). The neurodevelopmental hypothesis of schizophrenia, revisited. Schizophr. Bull 35: 528-548. http://dx.doi.org/10.1093/schbul/sbn187 PMid:19223657    PMCid:2669580 Fujiwara Y, Yamaguchi K, Tanaka Y, Tomita H, et al. (1997). Polymorphism of dopamine receptors and transporter genes in neuropsychiatric diseases. Eur. Neurol. 38 (Suppl 1): 6-10. http://dx.doi.org/10.1159/000113436 PMid:9276194 Glatt SJ, Faraone SV and Tsuang MT (2003). Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia. Mol. Psychiatry 8: 911-915. http://dx.doi.org/10.1038/sj.mp.4001321 PMid:14593428 Gupta M, Chauhan C, Bhatnagar P, Gupta S, et al. (2009). Genetic susceptibility to schizophrenia: role of dopaminergic pathway gene polymorphisms. Pharmacogenomics 10: 277-291. http://dx.doi.org/10.2217/14622416.10.2.277 PMid:19207030 Harano M (1997). Ser-311-Cys polymorphism of the dopamine D2 receptor gene and schizophrenia - an analysis of schizophrenic patients in Fukuoka. Kurume Med. J. 44: 201-208. http://dx.doi.org/10.2739/kurumemedj.44.201 PMid:9339651 Hattori M, Nanko S, Dai XY, Fukuda R, et al. (1994). Mismatch PCR RFLP detection of DRD2 Ser311Cys polymorphism and schizophrenia. Biochem. Biophys. Res. Commun. 202: 757-763. http://dx.doi.org/10.1006/bbrc.1994.1995 PMid:7914079 Higgins JP and Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat. Med. 21: 1539-1558. http://dx.doi.org/10.1002/sim.1186 PMid:12111919 Himei A, Koh J, Sakai J, Inada Y, et al. (2002). The influence on the schizophrenic symptoms by the DRD2Ser/Cys311 and -141C Ins/Del polymorphisms. Psychiatry Clin. Neurosci. 56: 97-102. http://dx.doi.org/10.1046/j.1440-1819.2002.00935.x PMid:11929577 Hori H, Ohmori O, Shinkai T, Kojima H, et al. (2001). Association analysis between two functional dopamine D2 receptor gene polymorphisms and schizophrenia. Am. J. Med. Genet. 105: 176-178. http://dx.doi.org/10.1002/ajmg.1196 PMid:11304833 Itokawa M, Arinami T, Futamura N, Hamaguchi H, et al. (1993). A structural polymorphism of human dopamine D2 receptor, D2(Ser311→Cys). Biochem. Biophys. Res. Commun. 196: 1369-1375. http://dx.doi.org/10.1006/bbrc.1993.2404 PMid:7902708 Jönsson EG, Sillen A, Vares M, Ekholm B, et al. (2003). Dopamine D2 receptor gene Ser311Cys variant and schizophrenia: association study and meta-analysis. Am. J. Med. Genet. B Neuropsychiatr. Genet. 119B: 28-34. http://dx.doi.org/10.1002/ajmg.b.20004 PMid:12707934 Kaneshima M, Higa T, Nakamoto H and Nagamine M (1997). An association study between the Cys311 variant of dopamine D2 receptor gene and schizophrenia in the Okinawan population. Psychiatry Clin. Neurosci. 51: 379-381. http://dx.doi.org/10.1111/j.1440-1819.1997.tb02603.x PMid:9472122 McGrath J, Saha S, Chant D and Welham J (2008). Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol. Rev. 30: 67-76. http://dx.doi.org/10.1093/epirev/mxn001 PMid:18480098 Morimoto K, Miyatake R, Nakamura M, Watanabe T, et al. (2002). Delusional disorder: molecular genetic evidence for dopamine psychosis. Neuropsychopharmacology 26: 794-801. http://dx.doi.org/10.1016/S0893-133X(01)00421-3 Nanko S, Hattori M, Dai XY, Fukuda R, et al. (1994). DRD2 Ser311/Cys311 polymorphism in schizophrenia. Lancet 343: 1044. http://dx.doi.org/10.1016/S0140-6736(94)90167-8 Ohara K, Nakamura Y, Xie DW, Ishigaki T, et al. (1996). Polymorphisms of dopamine D2-like (D2, D3, and D4) receptors in schizophrenia. Biol. Psychiatry 40: 1209-1217. http://dx.doi.org/10.1016/0006-3223(95)00673-7 Peters JL, Sutton AJ, Jones DR, Abrams KR, et al. (2006). Comparison of two methods to detect publication bias in meta-analysis. JAMA 295: 676-680. http://dx.doi.org/10.1001/jama.295.6.676 PMid:16467236 Sawa A and Snyder SH (2002). Schizophrenia: diverse approaches to a complex disease. Science 296: 692-695. http://dx.doi.org/10.1126/science.1070532 PMid:11976442 Seeman P (2010). Dopamine D2 receptors as treatment targets in schizophrenia. Clin. Schizophr. Relat. Psychoses 4: 56-73. http://dx.doi.org/10.3371/CSRP.4.1.5 Tanaka T, Igarashi S, Onodera O, Tanaka H, et al. (1996). Lack of association between dopamine D2 receptor gene Cys311 variant and schizophrenia. Am. J. Med. Genet. 67: 208-211. http://dx.doi.org/10.1002/(SICI)1096-8628(19960409)67:2<208::AID-AJMG12>3.0.CO;2-N Viechtbauer W (2007). Confidence intervals for the amount of heterogeneity in meta-analysis. Stat. Med. 26: 37-52. http://dx.doi.org/10.1002/sim.2514 PMid:16463355 Zhang Y, Bertolino A, Fazio L, Blasi G, et al. (2007). Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proc. Natl. Acad. Sci. U. S. A. 104: 20552- 20557. http://dx.doi.org/10.1073/pnas.0707106104 PMid:18077373    PMCid:2154469 Zintzaras E and Ioannidis JP (2005). Heterogeneity testing in meta-analysis of genome searches. Genet. Epidemiol. 28: 123-137. http://dx.doi.org/10.1002/gepi.20048 PMid:15593093